Jacob Steven Leach
Net Worth

Last updated:

What is Jacob Steven Leach net worth?

The estimated net worth of Mr. Jacob Steven Leach is at least $77,941,960 as of 16 Dec 2024. He owns shares worth $21,397,851 as insider, has earned $48,544,109 from insider trading and has received compensation worth at least $8,000,000 in DexCom, Inc..

What is the salary of Jacob Steven Leach?

Mr. Jacob Steven Leach salary is $1,000,000 per year as Executive Vice President & Chief Technology Officer in DexCom, Inc..

How old is Jacob Steven Leach?

Mr. Jacob Steven Leach is 47 years old, born in 1978.

What stocks does Jacob Steven Leach currently own?

As insider, Mr. Jacob Steven Leach owns shares in one company:

Company Title Shares Price per share Total value
DexCom, Inc. (DXCM) Executive Vice President & Chief Technology Officer 264,171 $81 $21,397,851

What does DexCom, Inc. do?

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

DXCM logo
DXCM
DexCom, Inc.
$81

Jacob Steven Leach insider trading

DexCom, Inc.

Mr. Jacob Steven Leach has made 25 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 744 units of DXCM stock worth $57,191 on 16 Dec 2024.

The largest trade he's ever made was exercising 47,600 units of DXCM stock on 28 Sep 2018. As of 16 Dec 2024 he still owns at least 264,171 units of DXCM stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 744 $76.87 $57,191
Sale
Common Stock 746 $69.15 $51,586
Sale
Common Stock 745 $115.05 $85,713
Sale
Common Stock 14,639 $134.41 $1,967,643
Sale
Common Stock 3,978 $123.64 $491,820
Sale
Common Stock 30,764 $125 $3,845,500
Sale
Common Stock 10,425 $114.45 $1,193,120
Sale
Common Stock 7,719 $115.13 $888,704
Sale
Common Stock 12,087 $476.7 $5,761,873
Sale
Common Stock 22,755 $395 $8,988,225
Sale
Common Stock 5,353 $362.92 $1,942,695
Sale
Common Stock 3,860 $398.3 $1,537,446
Sale
Common Stock 19,129 $376.74 $7,206,659
Sale
Common Stock 6,909 $253.77 $1,753,269
Option
Incentive Stock Option (right to buy) 11,458 $9.78 $112,059
Option
Common Stock 11,458 $9.78 $112,059
Sale
Common Stock 4,712 $147.77 $696,273
Sale
Common Stock 5,099 $145.74 $743,149
Option
Common Stock 4,797 $7.27 $34,874
Option
Incentive Stock Option (right to buy) 4,797 $7.27 $34,874
Sale
Common Stock 8,555 $142.79 $1,221,586
Sale
Common Stock 47,600 $143.73 $6,841,310
Option
Incentive Stock Option (right to buy) 15,000 $5.92 $88,800
Option
Common Stock 15,000 $5.92 $88,800
Sale
Common Stock 4,614 $143.76 $663,286
Option
Incentive Stock Option (right to buy) 20,577 $70.75 $1,455,905
Sale
Common Stock 10,577 $3.19 $33,741
Option
Common Stock 20,577 $70.75 $1,455,905
Sale
Common Stock 8,542 $84.77 $724,122
Option
Common Stock 8,745 $84.77 $741,331
Option
Non-Qualified Stock Option (right to buy) 203 $84.77 $17,209
Option
Common Stock 1,923 $3.19 $6,134
Sale
Common Stock 4,423 $44.17 $195,364
Option
Non-Qualified Stock Option (right to buy) 1,923 $3.19 $6,134
Sale
Common Stock 3,050 $77.32 $235,826
Sale
Common Stock 7,926 $77.92 $617,626
Option
Incentive Stock Option (right to buy) 7,500 $7.63 $57,225
Option
Common Stock 7,500 $7.63 $57,225
Sale
Common Stock 10,341 $77.4 $800,383

DexCom key executives

DexCom, Inc. executives and other stock owners filed with the SEC: